Global Drug Eluting Balloons (DEB) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Drug Eluting Balloons (DEB) market size will reach 890.82 Million USD in 2025 and is projected to reach 1,973.01 Million USD by 2032, with a CAGR of 12.03% (2025-2032). Notably, the China Drug Eluting Balloons (DEB) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Drug-eluting balloons (DEB) are medical devices used in interventional cardiology to treat narrowed or blocked blood vessels, typically in coronary arteries. These balloons are coated with a medication, usually an anti-proliferative drug, that is released into the vessel wall when the balloon is inflated. When the DEB is positioned at the site of the blockage and inflated, the drug is delivered to the tissue, helping to prevent restenosis (re-narrowing) of the vessel by inhibiting excessive cell growth. DEBs offer a localized and targeted drug delivery approach, combining the mechanical benefits of angioplasty with the therapeutic effects of drug therapy. They are commonly used as an alternative to drug-eluting stents in certain cases and are effective in improving the outcomes of patients undergoing vascular interventions.

The major global  manufacturers of Drug Eluting Balloons (DEB) include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotech, Philips, Aachen Resonance, Eurocor, Biotronic, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Drug Eluting Balloons (DEB). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Eluting Balloons (DEB) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Drug Eluting Balloons (DEB) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Eluting Balloons (DEB) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drug Eluting Balloons (DEB) Include:

B. Braun

Medtronic

Boston Scientific

BD

Yinyi Biotech

Philips

Aachen Resonance

Eurocor

Biotronic

Drug Eluting Balloons (DEB) Product Segment Include:

Peripheral DEBs

Coronary DEBs

Drug Eluting Balloons (DEB) Product Application Include:

Catheterization Laboratory

Hospital

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Drug Eluting Balloons (DEB) Industry PESTEL Analysis

Chapter 3: Global Drug Eluting Balloons (DEB) Industry Porter's Five Forces Analysis

Chapter 4: Global Drug Eluting Balloons (DEB) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Drug Eluting Balloons (DEB) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Drug Eluting Balloons (DEB) Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Drug Eluting Balloons (DEB) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more